Crossmark

Quantitative UPLC–MS/MS assay of urinary 2,8-dihydroxyadenine for diagnosis and management of adenine phosphoribosyltransferase deficiency

Crossref DOI link: https://doi.org/10.1016/j.jchromb.2016.09.018

Published Print: 2016-11

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Thorsteinsdottir, Margret

Thorsteinsdottir, Unnur A. http://orcid.org/0000-0002-8198-7948
Eiriksson, Finnur F.

Runolfsdottir, Hrafnhildur L.

Agustsdottir, Inger M.Sch.

Oddsdottir, Steinunn

Sigurdsson, Baldur B. http://orcid.org/0000-0002-2949-8725
Hardarson, Hordur K.

Kamble, Nilesh R.

Sigurdsson, Snorri Th.

Edvardsson, Vidar O.

Palsson, Runolfur
Funding

Funding for this research was provided by:

Rare Kidney Stone Consortium (U54DK083908)

NCATS

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
License Information

Text and Data Mining valid from 2016-11-01
More Information

This article is maintained by: Elsevier

Article Title: Quantitative UPLC–MS/MS assay of urinary 2,8-dihydroxyadenine for diagnosis and management of adenine phosphoribosyltransferase deficiency

Journal Title: Journal of Chromatography B

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.jchromb.2016.09.018

Content Type: article

Copyright: © 2016 Elsevier B.V. All rights reserved.